Outcomes were assessed at baseline, at week 16 (before the addition of empagliflozin or placebo to semaglutide) and after 32 weeks
In an interview with People , Williams said she was initially nervous about starting the medication, but now feels great. Despite the vocal backlash Serena Williams received after speaking about her journey with GLP-1s in August, it seems the 23-time Grand Slam winners influence is as strong as ever
served as site principal investigator for the clinical trial (he received no financial compensation, nor was there a financial relationship) and reports advisory/consulting fees and/or other support from Boehringer Ingelheim, Eli Lilly & Company, Guidotti Laboratories, Menarini Diagnostics, Novo Nordisk and Therascience Lignaform
M., Killian, L., et al
This program is tailored to your body, lifestyle, and goalsnot a one-size-fits-all approach What Is the GLP-1 Program